Disappointing Thanksgiving weekend sales weighed the markets down during the midday with the Dow losing 17 points to 16,069. Nasdaq slipped 6 points to 4053.
On the upside
B.O.S. Better Online Solutions (Nasdaq: BOSC) reported reversed year ago losses to post a profit for the third quarter as revenue rose.
A Seeking Alpha contributor wrote that Galena Biopharma (Nasdaq: GALE) was undervalued.
Shares of Novavax (Nasdaq: NVAX) rose ahead of its presentation at the 25th Annual Piper Jaffray Healthcare Conference tomorrow.
On the downside
Invitae sued Myriad Genetics (Nasdaq: MYGN) for infringing on its genetic testing patents.
Ingersoll-Rand (NYSE: IR) completed the spinoff of its Allegion commercial and residential security business.
Investors locked in profits on Genco Shipping & Trading (NYSE: GNK).
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on both the NYSE and on Nasdaq. The broader S&P 500 edged up a point to 1806. Bitcoin climbed $76.75 or 7.98% to $1,038.75.
